Yann Harnoy

Title: Yann Harnoy: Innovator in Ulcerative Colitis Research

Introduction

Yann Harnoy is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the study of ulcerative colitis and its complications. His innovative work has the potential to advance our understanding of this debilitating condition.

Latest Patents

Yann Harnoy holds a patent for a non-human animal model for ulcerative colitis and its main complications. This invention relates to a transgenic non-human animal model that exhibits a targeted disruption in the IL10 and NOX1 genes. As a result, IL10 and NOX1 are not expressed in the animal, allowing for a more accurate study of ulcerative colitis, primary sclerosing cholangitis, and colorectal cancer. This patent represents a significant advancement in the research of these serious health issues.

Career Highlights

Throughout his career, Yann Harnoy has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale. His research has focused on developing innovative models that can help in understanding complex diseases and their treatments.

Collaborations

Yann Harnoy has collaborated with notable colleagues, including Eric Ogier-Denis and Xavier Treton. These partnerships have contributed to the advancement of research in the field of ulcerative colitis.

Conclusion

Yann Harnoy's contributions to medical research, particularly through his patent on a non-human animal model for ulcerative colitis, highlight his role as an innovator in the field. His work continues to pave the way for future advancements in understanding and treating this condition.